Immunocore Holdings PLC (NAS:IMCR)
$ 32.22 -0.27 (-0.83%) Market Cap: 1.61 Bil Enterprise Value: 1.21 Bil PE Ratio: 0 PB Ratio: 4.30 GF Score: 66/100

Immunocore Holdings PLC at Barclays Global Healthcare Conference Transcript

Mar 15, 2023 / 07:35PM GMT
Release Date Price: $52.66 (-0.27%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

Thank you so much. Welcome to Barclays Healthcare Conference -- Global Healthcare Conference in Miami and do e-mail us or reach us on Bloomberg, if you have any questions, I can get them message to me. My name is Peter Lawson. I'm one of the SMID Cap Biotech Analyst at Barclays and focused on oncology-related companies and really delighted to have up on stage with me management from Immunocore. We have Brian Di Donato, CFO; and David Berman, Head of R&D.

Questions & Answers

Peter Richard Lawson;Brian R. Di Donato
Barclays Bank PLC, Research Division - Research Analyst;Immunocore Holdings plc - CFO & Head

And I guess my first question really going to be around, I guess, revenue growth and kind of how we should be thinking about it? You've done a fantastic job with over the last 3, 4 quarters on accelerated growth. How long does that story continue for? And what are the pushes and takes that we should be thinking about as we enter 2023.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot